Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial reactive oxygen species (ROS) generation and antioxidant defense systems comprise the integrated biochemical pathways responsible for producing and neutralizing oxidative byproducts within the mitochondria. ROS are primarily generated at Complexes I and III of the electron transport chain during oxidative phosphorylation (Murphy, 2009, Biochem J). To prevent cellular damage, the organelle utilizes an antioxidant network including manganese superoxide dismutase (MnSOD), catalase, and the glutathione/thioredoxin systems (Sies et al., 2017, Nat Rev Mol Cell Biol). Chronic imbalance between ROS production and antioxidant capacity leads to oxidative stress, which is implicated in the progression of neurodegenerative diseases like Parkinson's, cardiovascular dysfunction, and the aging process (Lin & Beal, 2006, Nature). Therapeutic interventions often involve mitochondria-targeted molecules, such as MitoQ or elamipretide, designed to selectively reduce oxidative burden within the organelle (Smith & Murphy, 2010, Free Radic Biol Med). However, because ROS also function as critical signaling molecules for processes like mitophagy and hypoxic adaptation, pharmacological modulation must be carefully balanced to avoid disrupting essential physiological pathways.
Mitochondria-targeted antioxidants accumulate in the mitochondrial matrix to scavenge reactive oxygen species, while other agents stabilize cardiolipin or enhance the activity of endogenous enzymes like superoxide dismutase to maintain redox balance (Smith & Murphy, 2010, Free Radic Biol Med; Szeto, 2014, Br J Pharmacol).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial reactive oxygen species generation and antioxidant defense systems (mROS/Antioxidant System).